Miracle Babies Foundation is governed by a Board of Directors who meet quarterly. The Board was formed in 2009 and originally Chaired by Morris Iemma. Miracle Babies Foundation staff are mostly based at head office at Chipping Norton, although several staff are based across Australia working in programs with hospitals and families. Our Ambassadors are a passionate and dedicated group, supporting the Foundation with their time to raise awareness and promote the Foundation.
Board, Staff, Ambassadors and Volunteers all work toward our vision of ‘better, healthier outcomes for newborns and their families challenged by prematurity or sickness.’
CEO, Co-Founder, Board Director, & Consumer Representative
Kylie Pussell Co-Founded Miracle Babies Foundation in 2005. After suffering a miscarriage and losing twin babies at 16 weeks, Kylie gave birth to her daughter Madeline at 30 weeks and was diagnosed with Cervical Incompetence. Madeline was cared for in Liverpool Hospital’s NICU for 6 weeks. Two years later, following a further miscarriage, Kylie delivered twins at just 25 weeks. Both were resuscitated at birth and cared for by the NICU. Sadly Kylie’s son Marcus passed away due to complications from his extreme prematurity. Her daughter Scarlet required ventilation and surgery. Scarlet was cared for in the NICU at Liverpool and Westmead Children’s Hospital and was discharged home just before her due date, 4 months later. Kylie’s son Liam was born at 38 weeks through planned c-section following a transabdominal cerclage. Kylie, a qualified counsellor, has played an integral role in the expansion of the Foundation’s program NurtureTime, the introduction of Miracle Babies Foundation to hospitals nationally and the development of national resources. She developed and implemented Miracle Babies Foundation’s successful volunteer program, designing National Volunteer Induction and Training with TAFE NSW. Kylie was selected in the inaugural The Growth Project in 2015. Kylie delivers presentations and forums on the Foundation to community and corporate, both nationally and internationally and shares her personal journey with her children, delivering parent support and positive change for premature and sick babies. Kylie highlights the needs for parents and families in the NICU and the years ahead. Kylie leads support for our bereaved families and assists families and educational institutions in the learning, social and emotional challenges some of these miracle babies experience in the early years, school aged years and adulthood. Kylie has been an instrumental leader in many new services the Foundation delivers, most recently Nurture ‘E’ – The EEE Impact. This information hub is designed to assist families through different life stages of their growing and developing child beyond the baby, infant and toddler years and supporting families through primary and high school right through to adulthood. Nurture E - The EEE Impact has been created in collaboration with parents and health professionals to provide families with Evidence, Education and Empowerment. She is CEO of the Foundation and passionate in driving the expansion of services and resources across Australia for all families to be supported, educated and empowered. Kylie was Secretary of the Board from 2009 to 2017 and appointed as CEO by the Board in 2017. Kylie is a Co-Investigator on the POD Study, POD 2 and a previous member of the PSANZ Perinatal Palliative Care Special Interest Group. In July 2019 Kylie became a Founding Committee member of GLANCE and in December 2019 was appointed to the Chair Committee for GLANCE. During 2019 and 2020 Kylie was a member of the Working Group on the ICHOM Preterm and Hospitalized Neonates Standard Set and in September 2020 was named Western Sydney Women – 2020 Community Woman of the Year. Kylie was also awarded ‘Highly Commended’ in the Western Sydney University Women of the West Awards for Community 2020. In July 2021 Kylie became a member of the World Prematurity Day Parent Advisory Board and the World Prematurity Day Global Planning Group. In April 2022 Kylie was awarded as a Finalist in the NSW Women Of The Year Award – Woman of Excellence. Kylie has been a Board Director since 2009.
Founder, Researcher, Consumer Representative, Advocacy & Secretary of the Board
Miracle Babies Foundation was initiated and founded by Melinda in 2005. Due to a bicornuate (heart shaped) uterus, Melinda’s first son, Elijah, was born at 34 weeks, spending 2 1/2 weeks in the Newborn Intensive Care Unit. Her second son Dillon was born at 27 weeks and resuscitated at birth. He spent 9 weeks in hospital before being allowed to go home. Melinda's third son Jasper was born at 37 weeks and also spent time in the NICU. Having had all 3 babies cared for by the NICU, Melinda wanted to remain linked to other mothers of premature babies. She also wanted to give back to the NICU and thank the wonderful staff she credits for saving her babies’ lives. It was from those experiences that the Miracle Babies Foundation was born and has since helped and supported thousands of families. The Foundation has established a major global impact, and the incredible difference it has made supporting families through the birth of a premature or sick baby has seen Melinda win numerous awards including the 2011 EY Social Entrepreneur of the Year and be a regular guest on radio, TV, podcasts and at conferences. In 2015, she was a NSW Woman of the Year - Premiers Award finalist. Melinda has a Bachelor of Science in Genetics and Nutritional Biochemistry. She is a trusted consumer expert to medical professionals seeking to improve treatments and understanding of the impact a preterm birth has on the family unit. In 2012, she was appointed an Honorary Research Associate at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (University of Sydney, School of Medicine) and was the first parent to be an Associate Investigator (2012) and Chief Investigator (2019) on neonatal trials. In 2014, Melinda joined the Perinatal Society of Australia and NZ (PSANZ) Consumer Advisory Panel and the PSANZ Clinical Trials executive committee. In 2015, she joined the Australian Red Cross Blood Service Milk Bank Advisory Committee. Melinda has been instrumental in a number of other trials such as assisting in obtaining waiver of consent for the TORPIDO 30/60 Trial and facilitating the support of Australian parents during the FiCare Trial. To date, Melinda has co-authored 11 medical publications. Melinda is also a contributor to THRIVE Global in which she has published six articles to date. In 2014, she ran the New York Marathon with a group of 18 raising over $230K for the Foundation. For three years in a row, she was an EY Australian Entrepreneur of the Year Judge and she is currently working on releasing her first book. Melinda has been a Board Director since 2009.